Enterprise League logo
AimMax Therapeutics, Inc. Logo

AimMax Therapeutics, Inc.

Durham, United States (US) · Health and Medical

Do your work at AimMax Therapeutics, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

AimMax Therapeutics is a Durham, North Carolina-based biopharmaceutical company focused on the research and development of innovative anti-infectives and anti-inflammatory therapeutics. Founded in 2017 by experienced pharmaceutical R&D professionals, we leverage a translational medicine approach to advance early-stage molecules through lead optimization, nonclinical and clinical testing.

Our core strength lies in our expertise in developing novel and improved anti-infectives targeting resistant bacteria, fungi, and other microorganisms. We are dedicated to understanding the molecules, the science, and disease models to accelerate the development process.

Currently, AimMax is focused on a key co-development project: an ophthalmic formulation of a corticosteroid with enhanced penetration and reduced dosing frequency for post-ocular surgery inflammation and pain management, currently with an NDA approved in March 2024. We are committed to benefiting patients and the healthcare community through scientific innovation.

Most teams do this before shortlisting


Contact Details

info@aimmaxrx.com

Durham, United States (US)

Founded

2017

Company Type

Private Limited Company

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after AimMax Therapeutics, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.